RNS Number:8343H
PPL Therapeutics PLC
21 February 2003

PPL Therapeutics plc ("the Company")

DISCLOSURE OF INTEREST

The Company received notification on 20 February 2003 from Metage Capital
Limited that Metage Funds Limited, have an interest in 12,379,110 Ordinary
shares in the Company, representing 10.43% of the Company's issued share
capital.

Of this total 8,754,110 Ordinary shares are held at Metage Funds Limited's
custodian, Credit Suisse First Boston (Europe) Ltd.


                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

HOLUASNROURUUAR